Lista de obras - George J Bosl - Dominio Público Uruguay

A method for assessing house staff workload as a function of length of stay

scientific article published on 01 September 2001

A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.

artículo científico publicado en 2011

Advances in Urologic Oncology: Results Progress From Successful Interdisciplinary Research

artículo científico publicado en 2006

Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent

artículo científico publicado en 2002

Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas

artículo científico publicado en 2002

Biology and genetics of adult male germ cell tumors

artículo científico publicado en 2006

Body Mass Index Is Associated With Higher Lymph Node Counts During Retroperitoneal Lymph Node Dissection ⬇️

artículo científico publicado el 14 de diciembre de 2011

CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity

artículo científico publicado en 2011

Carboplatin for stage I seminoma and the sword of Damocles

artículo científico publicado en 2005

Carboplatin in clinical stage I seminoma: too much and too little at the same time

artículo científico publicado en 2011

Characteristic promoter hypermethylation signatures in male germ cell tumors

artículo científico publicado en 2002

Chemotherapy for teratoma with malignant transformation

artículo científico publicado en 2003

Clinical Outcomes of Local and Metastatic Testicular Sex Cord-Stromal Tumors

artículo científico publicado en 2014

Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older

artículo científico publicado en 2013

Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer

artículo científico publicado en 2012

Clinical outcome and predictors of survival in late relapse of germ cell tumor

artículo científico publicado en 2008

Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour

artículo científico publicado en 2007

Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor

artículo científico publicado en 2003

Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors

artículo científico publicado en 2005

Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells

artículo científico publicado en 2006

Contemporary lymph node counts during primary retroperitoneal lymph node dissection.

artículo científico publicado en 2010

Curing germ cell tumors after failure of high-dose chemotherapy: progress through clinical trials

artículo científico publicado en 2007

Development and Validation of a Gene-Based Model for Outcome Prediction in Germ Cell Tumors Using a Combined Genomic and Expression Profiling Approach

artículo científico publicado en 2015

Development of a risk stratification system to guide treatment for female germ cell tumors.

artículo científico publicado en 2015

Double-Blind, Placebo-Controlled, Randomized Trial of Granulocyte-Colony Stimulating Factor During Postoperative Radiotherapy for Squamous Head and Neck Cancer

scientific article published on 01 May 2006

Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors

artículo científico publicado en 2006

Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors

artículo científico publicado en 2005

Evaluation of lymph node counts in primary retroperitoneal lymph node dissection.

artículo científico publicado en 2010

Expression of ID genes in differentiated elements of human male germ cell tumors

artículo científico publicado en 2001

Expression profiling of lineage differentiation in pluripotential human embryonal carcinoma cells.

artículo científico publicado en 2002

Gene expression-based classification of nonseminomatous male germ cell tumors

artículo científico publicado en 2005

Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes.

artículo científico publicado en 2002

ID gene expression varies with lineage during differentiation of pluripotential male germ cell tumor cell lines

artículo científico publicado en 2001

Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumour

artículo científico publicado en 2012

Improved Clinical Outcome in Recent Years for Men With Metastatic Nonseminomatous Germ Cell Tumors

article

In vivo differentiation and genomic evolution in adult male germ cell tumors

scientific article published on 01 January 2008

Incidence and Clinical Outcome of Patients with Teratoma in the Retroperitoneum Following Primary Retroperitoneal Lymph Node Dissection for Clinical Stages I and IIA Nonseminomatous Germ Cell Tumors

artículo científico publicado en 2003

Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.

artículo científico publicado en 2007

Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy

artículo científico publicado en 2005

Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.

artículo científico publicado en 2007

Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors

artículo científico publicado en 2008

Interrogation of a context-specific transcription factor network identifies novel regulators of pluripotency

artículo científico publicado en 2015

Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up

artículo científico

Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma

artículo científico publicado en 2007

Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse

scientific article published on 01 April 2001

Medical treatment of advanced testicular cancer.

artículo científico publicado en 2008

Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin.

artículo científico publicado en 2009

Nonrandomized Comparison of Primary Chemotherapy and Retroperitoneal Lymph Node Dissection for Clinical Stage IIA and IIB Nonseminomatous Germ Cell Testicular Cancer

artículo científico publicado en 2007

Optimal management of clinical stage I testis cancer: one size does not fit all.

artículo científico publicado en 2013

Outcomes After Resection of Postchemotherapy Residual Neck Mass in Patients With Germ Cell Tumors—An Update

artículo científico publicado en 2011

Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site.

artículo científico

Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide in Previously Treated Germ Cell Tumors

artículo científico publicado en 2007

Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer

scientific article published on 01 June 2000

Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors

artículo científico publicado en 2007

Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors

artículo científico publicado en 2009

Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors.

artículo científico publicado en 2015

Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors

artículo científico publicado en 2007

Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors

artículo científico publicado en 2000

Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors.

artículo científico publicado en 2009

Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors

artículo científico publicado en 2004

Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors

artículo científico publicado en 2007

Predicting Teratoma in the Retroperitoneum in Men Undergoing Post-Chemotherapy Retroperitoneal Lymph Node Dissection

article

Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy

artículo científico publicado en 2001

Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors.

artículo científico publicado en 2014

Primary retroperitoneal lymph node dissection in low-stage testicular germ cell tumors: a detailed pathologic study with clinical outcome analysis with special emphasis on patients who did not receive adjuvant therapy.

artículo científico publicado en 2013

Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design.

artículo científico publicado en 2011

RETROPERITONEAL LYMPH NODE DISSECTION IN PATIENTS WITH LOW STAGE TESTICULAR CANCER WITH EMBRYONAL CARCINOMA PREDOMINANCE AND/OR LYMPHOVASCULAR INVASION

scientific article published on 01 August 2005

Rare de novo germline copy-number variation in testicular cancer

artículo científico publicado en 2012

Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.

artículo científico publicado en 2014

Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors

scientific article published on 01 March 2000

Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition

artículo científico publicado en 2012

Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy

artículo científico publicado en 2004

Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome

articulo cientifico

Reply: To PMID 24094653.

artículo científico publicado en 2013

Resection of Primary Mediastinal Non-Seminomatous Germ Cell Tumors: A 28-Year Experience at Memorial Sloan-Kettering Cancer Center

scientific article published on 01 July 2011

Results of Retroperitoneal Lymph Node Dissection for Clinical Stage I and II Pure Embryonal Carcinoma of the Testis

artículo científico publicado en 2003

Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer: Impact of Patient Selection Factors on Outcome

artículo científico publicado en 2005

Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum

artículo científico publicado en 2001

Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors

artículo científico publicado en 2004

Salvage chemotherapy for patients with advanced pure seminoma

artículo científico publicado en 2002

Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients.

artículo científico publicado en 2000

Testicular Seminoma: A Clinicopathologic and Immunohistochemical Study of 105 Cases with Special Reference to Seminomas with Atypical Features

artículo científico publicado en 2002

Testicular granulosa cell tumors: rare tumors need to be studied too.

artículo científico publicado en 2009

Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas

artículo científico publicado en 2009

The future of therapy for nonseminomatous germ cell tumors.

artículo científico publicado en 2002

The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor

artículo científico publicado en 2008

Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells.

artículo científico publicado en 2005

Treatment of epidural spinal cord involvement from germ cell tumors with chemotherapy.

artículo científico publicado en 2010

Treatment of stage I seminoma: is it time to change your practice?

artículo científico publicado en 2008

Weighing Risks and Benefits of Postchemotherapy Retroperitoneal Lymph Node Dissection: Not So Easy

artículo científico publicado en 2009

miR-18b and miR-518b Target FOXN1 during epithelial lineage differentiation in pluripotent cells

scientific journal article

Lista de obras de George J Bosl

A method for assessing house staff workload as a function of length of stay

A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.

Advances in Urologic Oncology: Results Progress From Successful Interdisciplinary Research

Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent

Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas

Biology and genetics of adult male germ cell tumors

Body Mass Index Is Associated With Higher Lymph Node Counts During Retroperitoneal Lymph Node Dissection ⬇️

CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity

Carboplatin for stage I seminoma and the sword of Damocles

Carboplatin in clinical stage I seminoma: too much and too little at the same time

Characteristic promoter hypermethylation signatures in male germ cell tumors

Chemotherapy for teratoma with malignant transformation

Clinical Outcomes of Local and Metastatic Testicular Sex Cord-Stromal Tumors

Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older

Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer

Clinical outcome and predictors of survival in late relapse of germ cell tumor

Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour

Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor

Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors

Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells

Contemporary lymph node counts during primary retroperitoneal lymph node dissection.

Curing germ cell tumors after failure of high-dose chemotherapy: progress through clinical trials

Development and Validation of a Gene-Based Model for Outcome Prediction in Germ Cell Tumors Using a Combined Genomic and Expression Profiling Approach

Development of a risk stratification system to guide treatment for female germ cell tumors.

Double-Blind, Placebo-Controlled, Randomized Trial of Granulocyte-Colony Stimulating Factor During Postoperative Radiotherapy for Squamous Head and Neck Cancer

Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors

Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors

Evaluation of lymph node counts in primary retroperitoneal lymph node dissection.

Expression of ID genes in differentiated elements of human male germ cell tumors

Expression profiling of lineage differentiation in pluripotential human embryonal carcinoma cells.

Gene expression-based classification of nonseminomatous male germ cell tumors

Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes.

ID gene expression varies with lineage during differentiation of pluripotential male germ cell tumor cell lines

Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumour

Improved Clinical Outcome in Recent Years for Men With Metastatic Nonseminomatous Germ Cell Tumors

In vivo differentiation and genomic evolution in adult male germ cell tumors

Incidence and Clinical Outcome of Patients with Teratoma in the Retroperitoneum Following Primary Retroperitoneal Lymph Node Dissection for Clinical Stages I and IIA Nonseminomatous Germ Cell Tumors

Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.

Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy

Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.

Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors

Interrogation of a context-specific transcription factor network identifies novel regulators of pluripotency

Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up

Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma

Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse

Medical treatment of advanced testicular cancer.

Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin.

Nonrandomized Comparison of Primary Chemotherapy and Retroperitoneal Lymph Node Dissection for Clinical Stage IIA and IIB Nonseminomatous Germ Cell Testicular Cancer

Optimal management of clinical stage I testis cancer: one size does not fit all.

Outcomes After Resection of Postchemotherapy Residual Neck Mass in Patients With Germ Cell Tumors—An Update

Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site.

Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide in Previously Treated Germ Cell Tumors

Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer

Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors

Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors

Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors.

Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors

Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors

Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors.

Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors

Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors

Predicting Teratoma in the Retroperitoneum in Men Undergoing Post-Chemotherapy Retroperitoneal Lymph Node Dissection

Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy

Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors.

Primary retroperitoneal lymph node dissection in low-stage testicular germ cell tumors: a detailed pathologic study with clinical outcome analysis with special emphasis on patients who did not receive adjuvant therapy.

Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design.

RETROPERITONEAL LYMPH NODE DISSECTION IN PATIENTS WITH LOW STAGE TESTICULAR CANCER WITH EMBRYONAL CARCINOMA PREDOMINANCE AND/OR LYMPHOVASCULAR INVASION

Rare de novo germline copy-number variation in testicular cancer

Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.

Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors

Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition

Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy

Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome

Reply: To PMID 24094653.

Resection of Primary Mediastinal Non-Seminomatous Germ Cell Tumors: A 28-Year Experience at Memorial Sloan-Kettering Cancer Center

Results of Retroperitoneal Lymph Node Dissection for Clinical Stage I and II Pure Embryonal Carcinoma of the Testis

Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer: Impact of Patient Selection Factors on Outcome

Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum

Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors